Dirk Thye

1.9k total citations
18 papers, 1.0k citations indexed

About

Dirk Thye is a scholar working on Infectious Diseases, Pharmacology and Epidemiology. According to data from OpenAlex, Dirk Thye has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 9 papers in Pharmacology and 6 papers in Epidemiology. Recurrent topics in Dirk Thye's work include Antimicrobial Resistance in Staphylococcus (9 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Pneumonia and Respiratory Infections (6 papers). Dirk Thye is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (9 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Pneumonia and Respiratory Infections (6 papers). Dirk Thye collaborates with scholars based in United States, India and Canada. Dirk Thye's co-authors include George H. Talbot, Ian A. Critchley, H. David Friedland, Anita Das, Paul B. Eckburg, Taylor Sandison, Voon Ong, Gary W. Witherell, Yigong Ge and Lily Llorens and has published in prestigious journals such as Blood, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Dirk Thye

17 papers receiving 973 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dirk Thye United States 11 763 466 378 268 241 18 1.0k
Kenneth Klinker United States 19 575 0.8× 436 0.9× 494 1.3× 369 1.4× 189 0.8× 42 1.1k
H. David Friedland United States 19 958 1.3× 594 1.3× 529 1.4× 440 1.6× 345 1.4× 39 1.5k
Donald Hsu United States 11 868 1.1× 352 0.8× 324 0.9× 579 2.2× 147 0.6× 16 1.2k
Anthony M. Casapao United States 15 728 1.0× 283 0.6× 293 0.8× 435 1.6× 115 0.5× 29 879
Jeffrey Graves United States 8 860 1.1× 467 1.0× 363 1.0× 685 2.6× 239 1.0× 9 1.3k
Molly E. Steed United States 18 650 0.9× 315 0.7× 341 0.9× 363 1.4× 284 1.2× 29 959
Abdalhamid M Lagnf United States 18 468 0.6× 307 0.7× 317 0.8× 343 1.3× 366 1.5× 43 937
Jordan R. Smith United States 17 546 0.7× 216 0.5× 220 0.6× 275 1.0× 207 0.9× 27 781
Sungmin Kiem South Korea 16 314 0.4× 327 0.7× 359 0.9× 129 0.5× 250 1.0× 29 838
P. G. Pitsakis United States 16 652 0.9× 221 0.5× 307 0.8× 457 1.7× 234 1.0× 24 1.1k

Countries citing papers authored by Dirk Thye

Since Specialization
Citations

This map shows the geographic impact of Dirk Thye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Thye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Thye more than expected).

Fields of papers citing papers by Dirk Thye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Thye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Thye. The network helps show where Dirk Thye may publish in the future.

Co-authorship network of co-authors of Dirk Thye

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Thye. A scholar is included among the top collaborators of Dirk Thye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Thye. Dirk Thye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Lakota, Elizabeth A., Justin Bader, Dirk Thye, et al.. (2016). PK-PD Target Attainment Analyses to Support the Selection of Extended Interval CD101 Dosing Regimens. Open Forum Infectious Diseases. 3(suppl_1). 2 indexed citations
2.
Sandison, Taylor, et al.. (2016). Safety and Pharmacokinetics of CD101 IV, a Novel Echinocandin, in Healthy Adults. Antimicrobial Agents and Chemotherapy. 61(2). 123 indexed citations
3.
Sandison, Taylor, Voon Ong, & Dirk Thye. (2016). Pharmacokinetics, Safety, and Target Attainment of Single and Multiple Doses of CD101 IV. Blood. 128(22). 2197–2197. 1 indexed citations
4.
Jandourek, Alena, et al.. (2014). Efficacy of Ceftaroline Fosamil for Bacteremia Associated With Community-Acquired Bacterial Pneumonia. Hospital Practice. 42(1). 75–78. 9 indexed citations
5.
Friedland, H. David, Tanya O’Neal, Donald Biek, et al.. (2012). CANVAS 1 and 2: Analysis of Clinical Response at Day 3 in Two Phase 3 Trials of Ceftaroline Fosamil versus Vancomycin plus Aztreonam in Treatment of Acute Bacterial Skin and Skin Structure Infections. Antimicrobial Agents and Chemotherapy. 56(5). 2231–2236. 57 indexed citations
6.
Talbot, George H., Tanya O’Neal, Anita Das, & Dirk Thye. (2012). Prospective Study of the Wilson Severity-of-Illness Scoring System for Complicated Skin and Skin Structure Infections. Antimicrobial Agents and Chemotherapy. 57(1). 647–650. 4 indexed citations
7.
Eckburg, Paul B., et al.. (2012). Day 4 Clinical Response of Ceftaroline Fosamil Versus Ceftriaxone for Community-Acquired Bacterial Pneumonia. Infectious Diseases in Clinical Practice. 20(4). 254–260. 19 indexed citations
8.
Critchley, Ian A., Paul B. Eckburg, Alena Jandourek, et al.. (2011). Review of ceftaroline fosamil microbiology: integrated FOCUS studies. Journal of Antimicrobial Chemotherapy. 66(Supplement 3). iii45–iii51. 33 indexed citations
9.
10.
Louie, Arnold, Mariana Castanheira, Weiguo Liu, et al.. (2011). Pharmacodynamics of β-Lactamase Inhibition by NXL104 in Combination with Ceftaroline: Examining Organisms with Multiple Types of β-Lactamases. Antimicrobial Agents and Chemotherapy. 56(1). 258–270. 69 indexed citations
11.
12.
13.
Biek, D., Ian A. Critchley, Todd Riccobene, & Dirk Thye. (2010). Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity. Journal of Antimicrobial Chemotherapy. 65(Supplement 4). iv9–iv16. 81 indexed citations
14.
Corey, G. Ralph, et al.. (2010). CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections. Journal of Antimicrobial Chemotherapy. 65(Supplement 4). iv41–iv51. 138 indexed citations
15.
16.
17.
Talbot, George H., Dirk Thye, Anita Das, & Yigong Ge. (2007). Phase 2 Study of Ceftaroline versus Standard Therapy in Treatment of Complicated Skin and Skin Structure Infections. Antimicrobial Agents and Chemotherapy. 51(10). 3612–3616. 121 indexed citations
18.
Ahn, Samuel S., et al.. (1994). The isolation of a fibroblast growth inhibitor associated with perigraft seroma. Journal of Vascular Surgery. 20(2). 202–208. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenneth Klinker Breakdown of academic impact, for papers by H. David Friedland Breakdown of academic impact, for papers by Donald Hsu Breakdown of academic impact, for papers by Anthony M. Casapao Breakdown of academic impact, for papers by Jeffrey Graves Breakdown of academic impact, for papers by Molly E. Steed Breakdown of academic impact, for papers by Abdalhamid M Lagnf Breakdown of academic impact, for papers by Jordan R. Smith Breakdown of academic impact, for papers by Sungmin Kiem Breakdown of academic impact, for papers by P. G. Pitsakis
Rankless by CCL
2026